Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients

Maagdenberg, H.; Bierings, M.B.; Ommen, C.H. van; Meer, F.J.M. van der; Appel, I.M.; Tamminga, R.Y.J.; ... ; Maitland-van der Zee, A.H. (2018)

Article / Letter to editor

• adolescent
• anticoagulation
• child
• infant
• pharmacogenomics
• phenprocoumon
• thrombosis

• All authors: Maagdenberg, H.; Bierings, M.B.; Ommen, C.H. van; Meer, F.J.M. van der; Appel, I.M.; Tamminga, R.Y.J.; Cessie, S. le; Swen, J.J.; Straaten, T. van der; Boer, A. de; Maitland-van der Zee, A.H.
• Date: 2018-10-31
• Journal: Pharmacogenomics
• Volume: 19
• Issue: 15
• Pages: 1195 - 1202
• DOI: doi:10.2217/pgs-2018-0095